ophthalmology

News

Alcon to build digital platform to improve cataract surgery

Novartis’ ophthalmology division Alcon has announced plans to build a digital platform to streamline, simplify and improve cataract surgery for surgeons and patients.

News

Novartis challenges court ruling allowing use of Avastin in ...

Novartis is appealing against a High Court ruling that it is lawful for the NHS to prescribe Roche’s Avastin (bevacizumab) in an unlicensed use in wet age-related macular degeneration (AMD)

News

Ionis and Roche to develop RNAi AMD drug in $760m deal

Ionis and Roche have struck a deal worth up to $760 million (£575 million) to develop a drug to treat advanced age-related macular degeneration (AMD), a leading cause of blindness.

News

Novartis, Bayer consider appeal as court says Avastin can be...

England’s High Court has ruled it is lawful to use Roche’s Avastin (bevacizumab) in an unlicensed use in wet age-related macular degeneration (AMD) instead of more expensive approved drugs

News

Spark/Novartis eye gene therapy nears EU market – but at wha...

Spark Therapeutics’ and Novartis Luxturna gene therapy for a rare inherited eye disease has been okayed by European regulators, paving the way for an EU licence in the coming months.

Partner Content